Menin
Showing 1 - 19 of 19
Acute Myeloid Leukemia Trial in Houston (SNDX-5613, Venetoclax, ASTX727)
Recruiting
- Acute Myeloid Leukemia
- SNDX-5613
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 14, 2022
Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation Trial (Biospecimen Collection, Bone
Not yet recruiting
- Acute Myeloid Leukemia With KMT2A Rearrangement
- Acute Myeloid Leukemia With NPM1 Mutation
- Biospecimen Collection
- +7 more
- (no location specified)
Jun 1, 2023
Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia
Not yet recruiting
- Recurrent Acute Leukemia of Ambiguous Lineage
- +5 more
- Biospecimen Collection
- +12 more
- (no location specified)
Mar 8, 2023
Colorectal Cancer, Solid Tumors Trial (SNDX-5613, Chemotherapy)
Not yet recruiting
- Colorectal Cancer
- Solid Tumors
- (no location specified)
Feb 15, 2023
Relapsed/Refractory Leukemias, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia Trial in Kansas City, Cincinnati
Recruiting
- Relapsed/Refractory Leukemias
- +4 more
- SNDX-5613
- +2 more
-
Kansas City, Missouri
- +1 more
Jul 18, 2022
Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in Japan, United States (DSP-5336)
Recruiting
- Leukemia, Myeloid, Acute
- Leukemia, Lymphocytic, Acute
-
Houston, Texas
- +5 more
May 31, 2022
Temporomandibular Disorders Trial (Botulinum toxin type A, Isotonic saline 0,9%)
Not yet recruiting
- Temporomandibular Disorders
- Botulinum toxin type A
- Isotonic saline 0,9%
- (no location specified)
Jan 30, 2023
Depression, Anxiety, Quality of Life, Cancer Trial (Acceptance and Commitment Therapy, Psychoeducation Active Control)
Not yet recruiting
- Depression, Anxiety
- +2 more
- Acceptance and Commitment Therapy
- Psychoeducation Active Control
- (no location specified)
Oct 17, 2022
MEN1 Gene Mutation Trial in Basel (Leflunomide 20 mg)
Not yet recruiting
- MEN1 Gene Mutation
- Leflunomide 20 mg
-
Basel, SwitzerlandUnispital Basel
Nov 1, 2022
Overall Survival of Large Cell Neuroendocrine Lung Cancer
Completed
- Survival Outcomes of Patients With Pulmonary LCNEC
- (no location specified)
Jun 27, 2019
Type 1 Multiple Endocrine Neoplasia Cohort Study
Unknown status
- Type 1-Multiple Endocrine Neoplasia Syndrome
-
Dijon, FranceChu Dijon Bourgogne
Aug 23, 2017